Mass drug administration: time to consider drug pollution?

Orive, Gorka; Lertxundi, Unax

Orive, Gorka; Lertxundi, Unax.

Afiliación

Orive G; NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz 01006, Spain; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine, Vitoria-Gasteiz, Spain; University Institute for Regenerative Medicine and Oral Implantology, Eduardo Anitua Foundation, Vitoria-Gasteiz, Spain; Singapore Eye Research Institute, Singapore, Singapore. Electronic address: gorka.orive@ehu.eus.
Lertxundi U; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba Mental Health Network, Araba Psychiatric Hospital, Pharmacy Service, Vitoria-Gasteiz, Spain.

Lancet ; 395(10230): 1112-1113, 2020 04 04.

Article en En | MEDLINE | ID: mdl-32247389

Asunto(s)

Contaminación Ambiental; Administración Masiva de Medicamentos/efectos adversos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Contaminación Ambiental / Administración Masiva de Medicamentos Límite: Humans Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google